This article was originally published in The Gray Sheet
Executive SummaryLaunches Expo line of coronary angiographic catheters, the company's first diagnostic catheters. Scimed has received regulatory clearance for the 5F, 6F, and 7F diameter catheters during the past year. Scimed says the Expo catheters will be introduced slowly to U.S. hospitals to allow the company to conduct early market evaluations of the devices
You may also be interested in...
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.
The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.